283 related articles for article (PubMed ID: 26256079)
21. Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients.
Mauro M; Ugo P; Walton Z; Ali S; Rastellini C; Cicalese L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446098
[TBL] [Abstract][Full Text] [Related]
22. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma.
Allegretta M; Filmus J
Anticancer Agents Med Chem; 2011 Jul; 11(6):543-8. PubMed ID: 21554204
[TBL] [Abstract][Full Text] [Related]
24. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
Nassar A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
[TBL] [Abstract][Full Text] [Related]
25. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
26. Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.
Yu D; Dong Z; Yao M; Wu W; Yan M; Yan X; Qiu L; Chen J; Sai W; Yao D
Tumour Biol; 2013 Apr; 34(2):661-8. PubMed ID: 23192642
[TBL] [Abstract][Full Text] [Related]
27. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function.
Hu J; Li P; Song Y; Ge YX; Meng XM; Huang C; Li J; Xu T
J Cell Physiol; 2018 Jun; 233(6):4408-4422. PubMed ID: 28833094
[TBL] [Abstract][Full Text] [Related]
28. GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.
Attallah AM; El-Far M; Omran MM; Abdelrazek MA; Attallah AA; Saeed AM; Farid K
Tumour Biol; 2016 Sep; 37(9):12571-12577. PubMed ID: 27380057
[TBL] [Abstract][Full Text] [Related]
29. Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma.
Shao L; Yu X; Han Q; Zhang X; Lu N; Zhang C
Oncoimmunology; 2022; 11(1):2010894. PubMed ID: 36524206
[TBL] [Abstract][Full Text] [Related]
30. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
Kwack MH; Choi BY; Sung YK
Mol Cells; 2006 Apr; 21(2):224-8. PubMed ID: 16682817
[TBL] [Abstract][Full Text] [Related]
31. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
[TBL] [Abstract][Full Text] [Related]
32. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
33. [Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
Yu DD; Yao M; Chen J; Wang L; Yan MJ; Gu X; Qiu LW; Dong ZZ; Yao DF; Lu SL
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):452-8. PubMed ID: 24034848
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
35. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
36. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
[TBL] [Abstract][Full Text] [Related]
38. A novel multifunctional gold nanorod-mediated and tumor-targeted gene silencing of GPC-3 synergizes photothermal therapy for liver cancer.
Liu Y; Tan M; Fang C; Chen X; Liu H; Feng Y; Zhang Y; Min W
Nanotechnology; 2021 Apr; 32(17):175101. PubMed ID: 33445163
[TBL] [Abstract][Full Text] [Related]
39. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
